Express Scripts’ Proposed Acquisition of Caremark: An Antitrust White Paper

In this White Paper, the AAI urges the FTC to issue a second request
and conduct a thorough investigation of Express Scripts' proposed
acquisition of Caremark. The paper discusses potential anticompetitive
effects of combining two of the largest Pharmaceutical Benefit
Management firms in the U.S.
Click here for a version of the paper in Adobe Acrobat.